There’s a naive reading of Nestlé’s strategy: the company is selling assets because it’s under pressure. And there’s a more interesting one: it’s selling assets because it has a thesis about what it wants to become.
The difference between the two readings isn’t semantic. It determines whether Nestlé in 2030 is a more focused, more coherent group — or a weakened one that liquidated its assets under duress.
What Nestlé Has Sold — and Why
Over the past five years, Nestlé has divested or put up for sale entire categories: confectionery in the US (sold to Ferrero), bottled water (progressive disposal of several regional brands), and part of its premium ice cream business in certain geographies.
These divestitures share a common logic: the assets in question are capital-intensive, compete in markets where Nestlé isn’t a top-tier player, and benefit little from the group’s distinctive advantages — nutrition R&D, global distribution, health innovation capability.
Nestlé keeps what it can do better than anyone: products with a strong health-nutrition anchor (coffee with Nescafé/Nespresso, infant nutrition, medical nutrition, petfood via Purina). These categories carry durable advantages — regulatory moats, clinical reputation, premium pricing — that competitors can’t easily replicate.
The Nutrition Thesis as a Strategic Pivot
Nestlé’s pivot toward nutrition aligns with fundamental trends in the food market. Demand for functional products — those delivering a measurable health benefit — is growing faster than demand in standard categories.
Nestlé has built expertise in medical nutrition (Nestlé Health Science) that sets it apart from food-only competitors. Products like Boost, Modulen, or specialized infant formulas are assets with a regulatory moat — they require clinical validation that new entrants can’t shortcut.
This positioning converges with Nestlé’s ambitions in the aging population space. Senior nutrition is a structurally growing market, low-profile in communications but economically solid. Nestlé has been investing there for a decade.
The Limits of the Thesis
Divesting assets isn’t risk-free.
First risk: legibility. In the consumer’s mind, Nestlé remains the company behind Kit-Kat, Nescafé, and Perrier. The transformation into a “nutrition and health company” takes decades to register in public perception. The risk is creating a gap between internal strategy and external perception — making the corporate brand hard to read.
Second risk: concentration. A more focused group is also a more vulnerable one. If the petfood category slows, or if a reputational crisis hits infant nutrition, the group no longer has the same revenue diversification as a buffer.
Third risk: execution. Divesting well and acquiring the right assets is as much art as science. Nestlé has paid dearly for some acquisitions (Atkins Nutritionals, The Bountiful Company) and had to course-correct. The thesis is sound; execution still needs to prove itself over time.
What the Nestlé Case Tells the Industry
Nestlé is a near-ideal case study for understanding how a food giant can reinvent itself without starting from scratch.
The conclusion that imposes itself isn’t that selling is always good. It’s that coherence — between what you sell, what you keep, and what you claim to be — is the true measure of a strategy.
The coming years will tell whether Nestlé found the right direction — or whether, like other giants who sold assets under pressure, it liquidated resources it will come to regret.